Labcorp Agrees to Pay $14.5M to Resolve False Claims Act Allegations

Laboratory Corporation of America (Labcorp), a national clinical diagnostics company, has agreed to pay $14,500,000 to resolve allegations that it violated the False Claims Act by submitting false claims to Medicare Part B (Medicare) for medically unnecessary urine drug testing (UDT) for some patients conducted pursuant to a testing panel offered by Labcorp, called “Toxassure Comprehensive.”